Committed to helping Fight Disease
Reata’s lead candidates are being developed for the treatment of a variety of chronic and genetic diseases for which a substantial unmet need exists. Our pipeline of therapeutics is focused in two main pillars: neurology and chronic kidney disease (CKD).